Get access

Spinal myoclonus responsive to topiramate

Authors

  • Antonio Siniscalchi MD,

    1. Department of Neuroscience, “Annunziata” Hospital, Cosenza, Italy
    Search for more papers by this author
  • Franco Mancuso MD,

    1. Department of Neuroscience, “Annunziata” Hospital, Cosenza, Italy
    Search for more papers by this author
  • Emilio Russo MPharm,

    1. Department of Experimental and Clinical Medicine, University Magna Grecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, Italy
    Search for more papers by this author
  • Guido Ferreri Ibbadu MD,

    1. Department of Experimental and Clinical Medicine, University Magna Grecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, Italy
    Search for more papers by this author
  • Giovambattista De Sarro MD

    Corresponding author
    1. Department of Experimental and Clinical Medicine, University Magna Grecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Catanzaro, Italy
    • Department of Experimental and Clinical Medicine, University Magna Grecia of Catanzaro, Regional Pharmacovigilance Center, Mater Domini University Hospital, Via T. Campanella, 115, 88100 Catanzaro, Italy
    Search for more papers by this author

Abstract

Spinal segmental myoclonus rarely occurs in peripheral neurological disorders. There are no data about the efficacy of topiramate (TPM) on spinal myoclonus. We describe a patient whose segmental myoclonus in amputation stump was ameliorated markedly by TPM. © 2004 Movement Disorder Society

Get access to the full text of this article

Ancillary